当前位置:首页 - 行情中心 - 康惠制药(603139) - 财务分析

康惠制药

(603139)

  

流通市值:13.34亿  总市值:13.34亿
流通股本:9988.00万   总股本:9988.00万

康惠制药(603139)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润-0.02亿元,每股收益0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益101697.07万元,未分配利润36846.74万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产197257.88万元,负债95560.81万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入127,367,068.27672,960,241.75472,228,266.33269,296,817.15
营业总成本133,377,175.4685,241,049.88470,567,191.27261,293,980.78
营业利润-1,225,055.56-61,802,556.52,806,588.3711,724,094.77
利润总额-1,588,691.69-57,943,311.262,720,313.1711,634,366.14
净利润-2,482,990.6-50,775,196.371,105,939.768,927,928.07
其他综合收益-1,890,974.41--
综合收益总额-2,482,990.6-48,884,221.961,105,939.768,927,928.07
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计640,795,173.46708,224,860.35828,767,040.78862,302,557.07
非流动资产合计1,331,783,657.691,343,499,372.431,310,087,855.311,325,768,998.51
资产总计1,972,578,831.152,051,724,232.782,138,854,896.092,188,071,555.59
流动负债合计612,049,017.21706,915,747.27648,809,996.24678,894,084.32
非流动负债合计343,559,120.17324,887,733.66416,204,822.39420,900,665.62
负债合计955,608,137.381,031,803,480.931,065,014,818.631,099,794,749.94
归属于母公司股东权益合计949,852,903.11949,233,877.18982,948,329.36986,325,822.05
股东权益合计1,016,970,693.771,019,920,751.851,073,840,077.461,088,276,805.65
负债和股东权益合计1,972,578,831.152,051,724,232.782,138,854,896.092,188,071,555.59
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计179,435,753.02620,288,274.76429,735,988.71269,352,819.77
经营活动现金流出小计170,914,708.76692,422,612.56528,963,012.8349,162,023.18
经营活动产生的现金流量净额8,521,044.26-72,134,337.8-99,227,024.09-79,809,203.41
投资活动现金流入小计20,874,412.48105,121,999.148,711,177.8146,600,761.81
投资活动现金流出小计10,167,044.79151,087,204.3481,527,269.265,031,913.21
投资活动产生的现金流量净额10,707,367.69-45,965,205.23-32,816,091.39-18,431,151.4
筹资活动现金流入小计57,835,650.66325,861,401.48308,892,010.87275,089,802.77
筹资活动现金流出小计126,622,478.17271,215,047.41180,495,540.41149,163,532.47
筹资活动产生的现金流量净额-68,786,827.5154,646,354.07128,396,470.46125,926,270.3
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-49,558,415.56-63,453,188.97-3,646,645.0227,685,915.49
期末现金及现金等价物余额94,196,181.65142,819,621.86202,626,165.81233,958,726.32
TOP↑